Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
ISSU
Neuromeka
★
Neuromeka Sets First Issuance Price at 38,350 KRW for 122.6 Billion KRW Rights Offering, CEO's Stake May Drop to 14.26% Raising Dilution Concerns
06/18/2026 12:57 PM
MATR
Neuromeka
★
Neuromeka Announces 122.6 Billion KRW Rights Offering and 0.5-for-1 Stock Dividend, Diluting Existing Shareholders by 25.76%
06/18/2026 11:32 AM
EXCH
Neuromeka
★★
Neuromeka Announces First Issue Price of 38,350 Won for 25.76% Rights Offering, Raising Concerns of Shareholder Dilution
06/18/2026 11:29 AM
EXCH
Neuromeka
★
Neuromeka's Conversion Price Upward Adjustment Reduces Dilution Risk Amid Stock Price Rise
06/16/2026 04:31 PM
OWNR
Neuromeka
★
Neuromeka CEO Jonghoon Park Plans OTC Sale of Shares and Warrants to Fund Rights Offering Subscription
06/05/2026 05:41 PM
ISSU
Neuromeka
★★
Neuromeka Decides on 126.6B KRW Rights Offering at 39,600 KRW per Share... Largest Shareholder Stake May Drop to 14.67%, Raising Dilution Concerns
06/02/2026 05:05 PM
MATR
Neuromeka
★
Neuromeka Announces 126.58B KRW Rights Offering and 50% Stock Dividend - Discounted Issue Price of 39,600 KRW, Risks of Dilution and Price Decline
06/02/2026 04:25 PM
OWNR
Neuromeka
★
Master Heo Yeong-jin Exercises Stock Options, Stake Slightly Increases to 0.61%... Limited Impact on Minority Shareholders
05/26/2026 05:21 PM
OWNR
Neuromeka
★
Neuromeka Non-Registered Director Jeong Jong-pil Acquires 7,000 Additional Shares via Stock Option Exercise… Minor Ownership Change, Limited Impact on Shareholder Value
05/26/2026 05:19 PM
OWNR
Neuromeka
★
Neuromeka Non-Registered Officer Lee Jae-cheon Increases Stake to 0.18% via Stock Option Exercise… Profits from Low Exercise Price
05/26/2026 05:17 PM
OWNR
Neuromeka
★
Mirae Asset Global Investments Increases Stake in Neuromeka to 5.07% (11,990 Shares via ETF Creation)
05/21/2026 05:04 PM
ISSU
Neuromeka
★★★
Neuromeka Announces 150 Billion KRW Rights Offering - Aimed at Financial Restructuring and Facility Investment, Significant Dilution Risk
05/14/2026 05:50 PM
PERI
Neuromeka
★
Neuromeka: Q1 Operating Loss Continues, but Debt Ratio Sharply Improves to 101% Following CB Conversion
05/14/2026 05:27 PM
EXCH
Neuromeka
★
Decision to Increase Short-term Borrowing by KRW 10 Billion
05/08/2026 04:48 PM
OWNR
Neuromeka
★
Submission of Mass Holdings Report (Simplified Form)
05/04/2026 04:33 PM
«
1
2
»